JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
Net Income (Common)
JiangSu WuZhong Pharmaceutical Development Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200
|
Net Income (Common)
-¥95m
|
CAGR 3-Years
39%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Net Income (Common)
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Net Income (Common)
¥3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Net Income (Common)
¥4.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Net Income (Common)
¥4.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Net Income (Common)
-¥780.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is JiangSu WuZhong Pharmaceutical Development Co Ltd's Net Income (Common)?
Net Income (Common)
-95m
CNY
Based on the financial report for Mar 31, 2024, JiangSu WuZhong Pharmaceutical Development Co Ltd's Net Income (Common) amounts to -95m CNY.
What is JiangSu WuZhong Pharmaceutical Development Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
20%
Over the last year, the Net Income (Common) growth was -71%. The average annual Net Income (Common) growth rates for JiangSu WuZhong Pharmaceutical Development Co Ltd have been 39% over the past three years , 20% over the past five years .